Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2016-12-20 (9 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: PARIS (75015), Paris
PHARMACIE CENTRALE MIRABEAU : revenue, balance sheet and financial ratios
PHARMACIE CENTRALE MIRABEAU is a French company
founded 9 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in PARIS (75015),
this company of category PME
shows in 2022 a revenue of 2.7 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE CENTRALE MIRABEAU (SIREN 824081590)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
Revenue
N/C
N/C
2 677 218 €
N/C
N/C
N/C
1 835 171 €
1 510 666 €
Net income
142 821 €
120 139 €
170 492 €
257 746 €
97 861 €
67 545 €
58 193 €
22 479 €
EBITDA
N/C
N/C
259 063 €
N/C
N/C
N/C
98 030 €
55 397 €
Net margin
N/C
N/C
6.4%
N/C
N/C
N/C
3.2%
1.5%
Revenue and income statement
In 2024, PHARMACIE CENTRALE MIRABEAU generates positive net income of 143 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2024: 22 k€ -> 143 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
142 821 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 278%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 22%. The balance between equity and debt is satisfactory.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
277.756%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
22.492%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE CENTRALE MIRABEAU
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
519.017
339.982
234.19
152.638
80.474
544.992
395.086
277.756
Financial autonomy
13.033
18.423
24.238
30.734
43.563
13.128
16.629
22.492
Repayment capacity
21.813
8.803
None
None
None
5.689
None
None
Cash flow / Revenue
2.324%
4.313%
None%
None%
None%
7.122%
None%
None%
Sector positioning
Debt ratio
277.762024
2022
2023
2024
Q1: 16.45
Med: 58.41
Q3: 154.59
Average
In 2024, the debt ratio of PHARMACIE CENTRALE MIRABEAU (277.76) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
22.49%2024
2022
2023
2024
Q1: 28.92%
Med: 49.95%
Q3: 69.49%
Watch
In 2024, the financial autonomy of PHARMACIE CENTRALE MIRABEAU (22.5%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.
Repayment capacity
5.69 years2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Average
In 2022, the repayment capacity of PHARMACIE CENTRALE MIRABEAU (5.69) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 320.27. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
320.275
Liquidity indicators evolution PHARMACIE CENTRALE MIRABEAU
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
136.89
143.866
152.576
156.433
217.211
308.262
277.443
320.275
Interest coverage
10.477
4.862
None
None
None
12.063
None
None
Sector positioning
Liquidity ratio
320.272024
2022
2023
2024
Q1: 129.47
Med: 182.14
Q3: 260.79
Excellent
In 2024, the liquidity ratio of PHARMACIE CENTRALE MIRABEAU (320.27) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Interest coverage
12.06x2022
2022
Q1: 0.75x
Med: 2.51x
Q3: 5.16x
Excellent
In 2022, the interest coverage of PHARMACIE CENTRALE MIRABEAU (12.1x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE CENTRALE MIRABEAU
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
Operating WCR
199 514 €
147 107 €
0 €
0 €
0 €
260 922 €
0 €
0 €
Inventory turnover (days)
41
32
0
0
0
27
0
0
Customer payment term (days)
10
4
142
146
151
4
162
0
Supplier payment term (days)
42
34
743
640
646
32
747
0
Positioning of PHARMACIE CENTRALE MIRABEAU in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE CENTRALE MIRABEAU is estimated at
1 993 886 €
(range 1 388 511€ - 2 982 968€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
1388k€1993k€2982k€
1 993 886 €Range: 1 388 511€ - 2 982 968€
NAF 5 année 2024
Valuation method used
Net Income Multiple
142 821 €
×
14.0x
=1 993 887 €
Range: 1 388 511€ - 2 982 969€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE CENTRALE MIRABEAU with other companies in the same sector:
Frequently asked questions about PHARMACIE CENTRALE MIRABEAU
What is the revenue of PHARMACIE CENTRALE MIRABEAU ?
The revenue of PHARMACIE CENTRALE MIRABEAU in 2022 is 2.7 M€.
Is PHARMACIE CENTRALE MIRABEAU profitable?
Yes, PHARMACIE CENTRALE MIRABEAU generated a net profit of 143 k€ in 2024.
Where is the headquarters of PHARMACIE CENTRALE MIRABEAU ?
The headquarters of PHARMACIE CENTRALE MIRABEAU is located in PARIS (75015), in the department Paris.
Where to find the tax return of PHARMACIE CENTRALE MIRABEAU ?
The tax return of PHARMACIE CENTRALE MIRABEAU is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE CENTRALE MIRABEAU operate?
PHARMACIE CENTRALE MIRABEAU operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart